Diabetes Accelerates Steatohepatitis in Mice
The American Journal of Pathology · 2024-05 · 194 (5) · 693-707
DOI: 10.1016/j.ajpath.2024.01.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2024-05. Verfasst von Tuerdiguli Abuduyimiti und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Department of Biochemistry and …. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda Science Foundation, Japan Agency for Medical Research and Development.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Glucose lowering independently reduces liver fibrosis in human nonalcoholic fatty liver disease. This study investigated the impact of diabetes on steatohepatitis and established a novel mouse model for diabetic steatohepatitis. Male C57BL/6J mice were fed a 60% high-fat diet (HFD) and injected with carbon tetrachloride (CCl4) and streptozotocin (STZ) to induce diabetes. The HFD+CCl4+STZ group showed more severe liver steatosis, hepatocyte ballooning, and regenerative nodules compared with other groups. Diabetes up-regulated inflammatory cytokine-associated genes and increased the M1/M2 macrophage ratios in the liver. Single-cell RNA sequencing analysis of nonparenchymal cells in the liver showed that diabetes reduced Kupffer cells and increased bone marrow-derived recruited inflammatory macrophages, such as Ly6Chi-RM. Diabetes globally reduced liver sinusoidal endothelial cells (LSECs). Furthermore, genes related to the receptor for advanced glycation end products (RAGE)/Toll-like receptor 4 (TLR4) were up-regulated in Ly6Chi-RM and LSECs in mice with diabetes, suggesting a possible role of RAGE/TLR4 signaling in the interaction between inflammatory macrophages and LSECs. This study established a novel diabetic steatohepatitis model using a combination of HFD, CCl4, and STZ. Diabetes exacerbated steatosis, hepatocyte ballooning, fibrosis, regenerative nodule formation, and the macrophage M1/M2 ratios triggered by HFD and CCl4. Single-cell RNA sequencing analysis indicated that diabetes activated inflammatory macrophages and impairs LSECs through the RAGE/TLR4 signaling pathway. These findings open avenues for discovering novel therapeutic targets for diabetic steatohepatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Med…
- Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Life Sciences Division, Engineering and Technology Department, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Department of Bone and Joint Disease, National Center for Geriatrics and Gerontology, Obu, Japan.
- Department of Vascular Molecular Physiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Förderung
- Takeda Science Foundation
- Japan Agency for Medical Research and Development
Zitieren
APA
Abuduyimiti, T., Goto, H., Kimura, K., Oshima, Y., Tanida, R., Kamoshita, K., Leerach, N., Abuduwaili, H., Oo, H. K., Li, Q., Galicia-Medina, C. M., Takayama, H., Ishii, K. A., Nakano, Y., Takeshita, Y., Iba, T., Naito, H., Honda, M., Harada, K., …, & Takamura, T. (2024). Diabetes Accelerates Steatohepatitis in Mice. The American Journal of Pathology, 194(5), 693-707. https://doi.org/10.1016/j.ajpath.2024.01.007
Vancouver
Abuduyimiti T, Goto H, Kimura K, Oshima Y, Tanida R, Kamoshita K, et al. Diabetes Accelerates Steatohepatitis in Mice. The American Journal of Pathology. 2024;194(5):693-707. doi:10.1016/j.ajpath.2024.01.007
BibTeX
@article{Abuduyimiti2024,
author = {Abuduyimiti, Tuerdiguli and Goto, Hisanori and Kimura, Kumi and Oshima, Yu and Tanida, Ryota and Kamoshita, Kyoko and Leerach, Nontaphat and Abuduwaili, Halimulati and Oo, Hein Ko and Li, Qifang and Galicia-Medina, Cynthia M and Takayama, Hiroaki and Ishii, Kiyo-Aki and Nakano, Yujiro and Takeshita, Yumie and Iba, Tomohiro and Naito, Hisamichi and Honda, Masao and Harada, Kenichi and Yamamoto, Yasuhiko and Takamura, Toshinari},
title = {Diabetes Accelerates Steatohepatitis in Mice},
journal = {The American Journal of Pathology},
year = {2024},
volume = {194},
number = {5},
pages = {693--707},
doi = {10.1016/j.ajpath.2024.01.007}
}
EUVIMED